Session 744 - Science and Engineering in Crystallization


Pharmaceuticals
Session 744 - Science and Engineering in Crystallization
Robust crystallization of API with desired properties often requires a seamless interface between crystallization science and engineering principles. Crystallization science governs the chemical interactions that drive both nucleation and growth. Engineering principles provide the tools for scale-up and finesse the process. In this section, we invite authors to submit papers that apply both science and engineering to solve challenging scale-up problems, such as polymorph and enantiomer crystallization, particle size manipulation, and habit modification, to name a few.
Chair:	Hector Guzman
CoChair:	Monica H. Lamm
CoSponsor(s):	Crystallization and Evaporation
	744a	Linear Models for Prediction of Ibuprofen Crystal Morphology Based on Hydrogen Bonding Propensities Charles Acquah, Arunprakash T. Karunanithi, Matthew Cagnetta, Luke E. K. Achenie, Steven Suib
	744b	Mechanism of the Formation of Enantiotropic Polymorphs in Solution Crystallization Wenju Wu
	744c	Polymorph Selection In Solution Crystallization: Is Kinetics the Primary Determinant? Sendhil K. Poornachary, Guangjun Han, Pui Shan Chow, Reginald B. H Tan
	744d	Mechanistic Model for the Effect of Molecular Imposters on the Shape of Molecular Organic Crystals Jacob P. Sizemore, M. F. Doherty
	744e	Precise Tailoring of the Crystal Size Distribution by Optimal Seeding Time Profiles Nicholas Kee, Xing Yi Woo, Reginald B. H Tan, Richard D. Braatz
	744f	Development and Scale-up of a Seeded Acidic Co-Addition Crystallization Adam S. Butterbaugh, Kevin D. Seibert, Paul C. Collins
	744g	Systematic Design of Supersaturation Controlled Crystallization Processes Zoltan K. Nagy, Erum AAmir, Chris Rielly

See more of Food, Pharmaceutical & Bioengineering Division

See more of The 2008 Annual Meeting

Pharmaceuticals